GMO U.S. Value ETF (NYSEARCA:GMOV) Sees Significant Increase in Short Interest

GMO U.S. Value ETF (NYSEARCA:GMOV) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 13,609 shares, an increase of 219.0% from the May 31st total of 4,266 shares. Currently, 0.5% of the company’s stock are short sold. Based on an average daily trading volume, of 16,719 shares, the short-interest ratio is currently 0.8 days.

GMO U.S. Value ETF Stock Performance

Shares of NYSEARCA GMOV traded up $0.30 during midday trading on Friday, reaching $30.17. 3,983 shares of the company’s stock were exchanged, compared to its average volume of 15,650. GMO U.S. Value ETF has a 52-week low of $24.79 and a 52-week high of $30.57. The stock has a market capitalization of $87.49 million, a PE ratio of 12.08 and a beta of 0.64. The business’s fifty day moving average price is $29.83 and its two-hundred day moving average price is $28.85.

Institutional Investors Weigh In On GMO U.S. Value ETF

A number of hedge funds have recently bought and sold shares of GMOV. Fifth Third Bancorp acquired a new position in shares of GMO U.S. Value ETF in the 1st quarter valued at approximately $84,000. Kestra Private Wealth Services LLC bought a new stake in shares of GMO U.S. Value ETF in the first quarter worth $333,000. Aspen Investment Management Inc bought a new stake in shares of GMO U.S. Value ETF in the fourth quarter worth $333,000. RPS Advisory Solutions LLC acquired a new stake in GMO U.S. Value ETF in the fourth quarter valued at $484,000. Finally, J.W. Cole Advisors Inc. raised its holdings in GMO U.S. Value ETF by 128.7% in the fourth quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock valued at $784,000 after acquiring an additional 16,044 shares in the last quarter.

About GMO U.S. Value ETF

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.